EUVIMEDEUVIMED entdecken
Crossref

Summary for Patients: Metformin Use in the First Trimester of Pregnancy and Risk for Nonlive Birth and Congenital Malformations

Annals of Internal Medicine · 2024

DOI: 10.7326/p24-0002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Internal Medicine, 2024. Hauptthemen laut MEDLINE: Metformin, Pregnancy Trimester, First, Hypoglycemic Agents, Abnormalities, Drug-Induced.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminPregnancy Trimester, FirstHypoglycemic AgentsAbnormalities, Drug-InducedHumansPregnancyFemaleRisk FactorsInfant, Newborn

Substanzen

MetforminHypoglycemic Agents

Zitieren

APA

(2024). Summary for Patients: Metformin Use in the First Trimester of Pregnancy and Risk for Nonlive Birth and Congenital Malformations. Annals of Internal Medicine. https://doi.org/10.7326/p24-0002

Vancouver

Summary for Patients: Metformin Use in the First Trimester of Pregnancy and Risk for Nonlive Birth and Congenital Malformations. Annals of Internal Medicine. 2024. doi:10.7326/p24-0002

BibTeX
@article{euvimed2024,
  title = {Summary for Patients: Metformin Use in the First Trimester of Pregnancy and Risk for Nonlive Birth and Congenital Malformations},
  journal = {Annals of Internal Medicine},
  year = {2024},
  doi = {10.7326/p24-0002}
}
Kostenlos starten →